Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (25)

2024

  1. RhoA downregulation in the murine intestinal epithelium results in chronic Wnt activation and increased tumorigenesis

    iScience, Vol. 27, Núm. 4

2023

  1. Delivery Systems in Ocular Retinopathies: The Promising Future of Intravitreal Hydrogels as Sustained-Release Scaffolds

    Pharmaceutics, Vol. 15, Núm. 5

  2. Extracellular vesicles secreted by triple-negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs

    International Journal of Cancer, Vol. 152, Núm. 10, pp. 2153-2165

2022

  1. Epithelial de-differentiation triggered by co-ordinate epigenetic inactivation of the EHF and CDX1 transcription factors drives colorectal cancer progression

    Cell Death and Differentiation, Vol. 29, Núm. 11, pp. 2288-2302

  2. Myosin Vb as a tumor suppressor gene in intestinal cancer

    Oncogene, Vol. 41, Núm. 49, pp. 5279-5288

2021

  1. Dickkopf-1 inhibition reactivates Wnt/β-catenin signaling in rhabdomyosarcoma, induces myogenic markers in vitro and impairs tumor cell survival in vivo

    International Journal of Molecular Sciences, Vol. 22, Núm. 23

2019

  1. Glucocorticoids and myosin5b loss of function induce heightened PKA signaling in addition to membrane traffic defects

    Molecular Biology of the Cell, Vol. 30, Núm. 26, pp. 3076-3089

2018

  1. Silencing of adaptor protein SH3BP2 reduces KIT/PDGFRA receptors expression and impairs gastrointestinal stromal tumors growth

    Molecular Oncology, Vol. 12, Núm. 8, pp. 1383-1397

2017

  1. Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer

    Scientific Reports, Vol. 7

  2. Loss of the EPH receptor B6 contributes to colorectal cancer metastasis

    Scientific Reports, Vol. 7

2015

  1. Myo5b knockout mice as a model of microvillus inclusion disease

    Scientific Reports, Vol. 5

2014

  1. RHOA inactivation enhances Wnt signalling and promotes colorectal cancer

    Nature Communications, Vol. 5

  2. The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like Factor 5 (KLF5)-defendent manner

    Journal of Biological Chemistry, Vol. 289, Núm. 36, pp. 25306-25316

2013

  1. Brush border myosin Ia inactivation in gastric but not endometrial tumors

    International Journal of Cancer, Vol. 132, Núm. 8, pp. 1790-1799

2012

  1. Brush border Myosin Ia has tumor suppressor activity in the intestine

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, Núm. 5, pp. 1530-1535

  2. Human SMC2 protein, a core subunit of human condensin complex, is a novel transcriptional target of the WNT signaling pathway and a new therapeutic target

    Journal of Biological Chemistry, Vol. 287, Núm. 52, pp. 43472-43481

2010

  1. Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment

    Clinical Cancer Research, Vol. 16, Núm. 8, pp. 2375-2382

  2. Mutations in the circadian gene CLOCK in colorectal cancer

    Molecular Cancer Research, Vol. 8, Núm. 7, pp. 952-960

2009

  1. The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis

    Cancer Research, Vol. 69, Núm. 18, pp. 7430-7438

2008

  1. Transforming pathways unleashed by a HDAC2 mutation in human cancer

    Oncogene, Vol. 27, Núm. 28, pp. 4008-4012